Poulton Jeffrey

Biography

Jeffrey “Jeff” served as Interim Chief Financial Officer from January 1, 2015, prior to his appointment as Chief Financial Officer. Jeff will resign from the Board with effect from the end of 2017. Skills & experience: Jeff brings to the Board his financial, commercial and strategic acumen. Since joining Shire in 2003 he has held leadership positions in finance supporting the Neuroscience, Gastrointestinal and Rare Diseases business units as well as the positions of Interim Chief Financial Officer and Head of Investor Relations. In addition, Jeff oversaw the operations of the Rare Diseases business unit in North America, Latin America and Asia Pacific, as well as leading the integration of the legacy-Viropharma rare disease products into the Shire portfolio. Prior to joining Shire, Jeff worked at Cinergy Corp. and PPG Industries in a variety of corporate finance and business development roles, in addition to serving as a commissioned officer in the U.S. Navy.

Research Interest

Healthcare